Company Performance Metrics
- Tom Large: CEO & Co-Founder
- Kerry Spear: CSO & Co-Founder
Blue Oak Pharmaceuticals is a pharmaceutical company that is committed to finding the next generation of drugs for brain disorders. They believe that first-in-class drugs will be discovered by integrating novel, custom-designed privileged chemotypes with validated in vivo systems neurobiology assays and brain circuit imaging.
Blue Oak drug hunters
are experts in the systems neurobiology of brain disorders, medicinal chemistry, and informatics. Their productivity integrates a “global research team” that integrates established partners with cutting-edge technologies in behavioral profiling, synthetic chemistry, and brain imaging. They advance first-in-class clinical candidates to early phase proof-of-concept studies using translational medicine biomarkers for brain circuit activity.
It was founded in 2016 and is headquartered in Waltham, Massachusetts.
